AKT protein kinase inhibitors

Details for Australian Patent Application No. 2004293026 (hide)

Owner Array BioPharma Inc.

Inventors Spencer, Keith L.; Rao, Chang; Munson, Mark; Vigers, Guy P. A.; Stengel, Peter; Xu, Riu; Miller, Scott; Han, Yongxin; Xiao, Dengming; Blake, James; Josey, John; Bernacki, April L.; Piscopio, Anthony; Kallan, Nicholas C.; Mitchell, Ian S.; Wang, Bin

Agent Pizzeys

Pub. Number AU-B-2004293026

PCT Pub. Number WO2005/051304

Priority 60/524,003 21.11.03 US

Filing date 19 November 2004

Wipo publication date 9 June 2005

Acceptance publication date 19 January 2012

International Classifications

C07D 253/00 (2006.01) Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61K 31/53 (2006.01) - having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine

C07D 257/12 (2006.01) Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms

C07D 401/00 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

25 May 2006 PCT application entered the National Phase

  PCT publication WO2005/051304 Priority application(s): WO2005/051304

19 January 2012 Application Accepted

  Published as AU-B-2004293026

17 May 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004293027-Enhanced drug delivery

2004293024-Method and device for cavity obliteration